| Items | Drug Registration information |
|---|---|
| ID | 1586 |
| No | 1586 |
| Brand Name | ALIBETEZIN |
| Ingredients | DAPAGLIFLOZIN 10 MG |
| Dosage Form | TABLET |
| Primary Packaging | BLISTERPACK |
| Storage | |
| Shelf Life | 2 YEARS |
| Pack Size | BOX OF 2 AND 50 X 7'S |
| Dispensing Category | |
| ATC Classification | |
| Pharmaceutical Class | |
| Indications | AS AN ADJUNCT TO DIET AND EXCERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES, TO REDUCE THE RISK OF HOSPITALIZATION FOR HEART FAILURE IN ADULT WITH TYPE 2 DIABETES MELLITUS AND EITHER ESTABLISHED CARDIOVASCULAR DISEASE OR MULTIPLE CARDIOVASCULAR RISK FACTOR |
| Contraindications | |
| Side Effects | |
| Unit Price | |
| EDL | NULL |
| Description | YELLOW TABLETS |
| Note | |
| License Owner | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
| Manufacturer | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
| Country | LAOS |
| Import Registration No | |
| Import Registration Date | |
| Activity | CERTIFICATE RELEASED |
| Applied Date | |
| FDD Registration No | 08 L 1177/24 |
| FDD Registration Date | 28/08/2024 |
| Expiry Date | 27/08/2027 |